Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

GSK-3 in neuronal plasticity and neurodegeneration: basic mechanisms and pre-clinical assessment

NEURO.GSK3

Neuronal circuits in mammalian brain act predominantly via excitatory synapses on dendritic spines. Formation of new spines in adult brain constitutes the structural basis of neuronal plasticity. The underlying molecular mechanisms remain largely unknown but depend essentially on kinase-dependent signalling pathways. Final formation of synapses on...

Funding Programme
Start Date
End Date
Total Funding
€ 5 082 027
European Countries Involved

Identification of the process by which patients recall and UPDATE their subjective RISK assessments for various diseases to incorporate objective genetic risk information

RISK-UPDATE

Project RISK-UPDATE will support the reintegration of Dr Talya Miron-Shatz, after four years spent as post-doctoral research collaborator with Nobel Laureate Prof. Daniel Kahneman at Princeton University, in the USA. Dr Miron-Shatz’s new host institution is Ono Academic College, Israel, which has agreed to set up a new research centre to facilitate...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Immune checkpoint blockade for fighting Alzheimer’s disease

ImmuneCheckpointsAD

Understanding, and ultimately treating Alzheimer’s disease (AD) is a major need in Western countries. Currently, there is no available treatment to modify the disease. Several pioneering discoveries made by my team, attributing a key role to systemic immunity in brain maintenance and repair, and identifying unique interface between the brain’s...

Funding Programme
Start Date
End Date
Total Funding
€ 2 287 500
European Countries Involved

Initial Training Network for Neurogical disorders orchestrated by cytoKines

NEUROKINE

Neuroinflammatory disease, in particular multiple sclerosis affects more than 700.000 people within Europe alone. European countries are at the forefront of neuroimmunological research and students in medicine and biology are greatly attracted by the field. Neuroimmunology research further impacts our understanding of the ethiopathology of other...

Funding Programme
Start Date
End Date
Total Funding
€ 3 536 796

Interferometric Microscopy and Nanoscopy in Live Biological Cells and Tissues

IMANILBCAT

The current research proposes new optical spectroscopic and interferometric microscopy and nanoscopy techniques for accurate measurements and visualization of biological cell structure, organization, stiffness and dynamics by recording the cell spatial, temporal, and refractive-index structure on sub-wavelength and sub-Hertz scales. The following...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Luminescent polymers for in vivo imaging of amyloid signatures

LUPAS

In this project we seek to develop new smart imaging molecular tools for combating neurodegenerative diseases such as Alzheimer’s disease and prion diseases. Emphasis is put on translational applied research for the development and validation of novel properly functionalized luminescent conjugated polymers (LCP) that via modern imaging technology...

Funding Programme
Start Date
End Date
Total Funding
€ 6 475 643
European Countries Involved

Memory research: Ground-breaking, Applied, and Technological Exchanges

M-GATE

In M-GATE, ESRs will combine state-of-the art experimental neurophysiology, innovative technologies, and advanced theoretical approaches to unveil memory mechanisms, from single neurons to brain networks, to cognition and behaviour, addressing the healthy and diseased brain. Through research and training from top-class scientists and close...

Funding Programme
Start Date
End Date
Total Funding
€ 3 961 160
European Countries Involved

Non-invasive detection of interictal epileptiform discharges (IEDs) in the mesial temporal lobe (MTL) during sleep

InterictalSleepDetct

Interictal epileptic discharges (IEDs) are pathological brain activities involving sharp spikes in electrical field potentials that occur preferentially during sleep. In epilepsy, IEDs occur between seizures, and often in deep brain regions such as the medial temporal lobe (MTL).IEDs during sleep disrupt memory and are associated with cognitive...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

NUtrition and microVAScular dynamics in COGnitive health

NUVASCOG

This IRG will support my return to the EU as a Senior Lecturer in Nutrition and Neuroscience at the Hebrew University of Jerusalem, bringing state-of-the-art science and technology, collaborations, and excellent prospects for reintegration and the enhancement of European competitiveness. My research aims to elucidate the metabolic basis of brain...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Orientation and disorientation in health and disease

Orientation

Orientation in space, time, and person is the essence of the behaving self, and the bedrock of neurological and psychiatric mental status examination. States of disorientation may be the hallmark manifestation of several neuropsychiatric disorders. Despite orientation’s central role in health and disease, orientation has almost never been a subject...

Funding Programme
Start Date
End Date
Total Funding
€ 164 378
European Countries Involved

Predicting odor perception from odorant structure and neural activity in the olfactory system

ODORSPACE

The rules linking odor perception to odorant structure are unknown. No scientist nor perfumer can predict an odor based on its molecular structure, or decipher a molecular structure based on its smell. It is this puzzle we aim to solve. In vision and audition coding was probed by linking critical physical stimulus dimensions (wavelength/frequency)...

Funding Programme
Start Date
End Date
Total Funding
€ 1 596 000
European Countries Involved

Presynaptic and astrocytic role of Amyloid precursor protein signaling in the hippocampus

ABETAPRESYNASTRO

Amyloid beta peptide (Abeta) is a normal product of the amyloid precursor protein (APP) proteolysis in the brain. While Abeta synaptotoxicity has been extensively studied as central to Alzheimer's disease (AD) pathogenesis, the mechanisms by which physiological Abeta regulates synapse function remain unknown. Utilizing two-photon excitation laser...

Funding Programme
Start Date
End Date
Total Funding
€ 50 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).